Helping to share the web since 1996
Nivolumab, marketed as Opdivo, is a humanized IgG4 anti-PD-1 monoclonal antibody used to treat cancer. Nivolumab works as a checkpoint inhibitor, blocking a signal that would have prevented activated T cells from attacking the cancer, thus allowing.
https://www.bocsci.com/nivolumab-cas-946414-94-4-item-470957.htmlalexdean2017 can login to edit this page by adding news and offers from their website.